ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Cyanocobalamin Injection Market Research Report 2025
Published Date: August 2025
|
Report Code: QYRE-Auto-34D8478
Home | Market Reports | Health| Nutrition| Vitamins & Supplements
Global Cyanocobalamin Injection Market Insights and Forecast to 2028
BUY CHAPTERS

Global Cyanocobalamin Injection Market Research Report 2025

Code: QYRE-Auto-34D8478
Report
August 2025
Pages:91
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Luitpold Pharmaceuticals
Luitpold Pharmaceuticals (Daiichi Sankyo)
Endo International
Bristol–Myers Squibb
Sanofi Aventis
Jamieson
Teva (Actavis)
Merck
Mylan NV
Bayer HealthCare
Pfizer Inc
Angelini
Biological E.
CCEPCD
Huaxin Pharmaceutical

Cyanocobalamin Injection Market

The global market for Cyanocobalamin Injection was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Cyanocobalamin is a man-made form of vitamin B12 used to prevent and treat low blood levels of this vitamin. Most people get enough vitamin B12 from their diet. Vitamin B12 is important to maintain the health of your metabolism, blood cells, and nerves.
North American market for Cyanocobalamin Injection is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Cyanocobalamin Injection is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Cyanocobalamin Injection include Luitpold Pharmaceuticals, Luitpold Pharmaceuticals(Daiichi Sankyo), Endo International, Bristol-Myers Squibb, Sanofi-Aventis, Jamieson, Teva(Actavis), Merck, Mylan, Bayer HealthCare, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Cyanocobalamin Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cyanocobalamin Injection.
The Cyanocobalamin Injection market size, estimations, and forecasts are provided in terms of sales volume (K Doses) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Cyanocobalamin Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cyanocobalamin Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Cyanocobalamin Injection Market Report

Report Metric Details
Report Name Cyanocobalamin Injection Market
Segment by Type
  • Vitamins
  • Supplements
Segment by Application
  • Hospitals
  • Clinics
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Luitpold Pharmaceuticals, Luitpold Pharmaceuticals(Daiichi Sankyo), Endo International, Bristol-Myers Squibb, Sanofi-Aventis, Jamieson, Teva(Actavis), Merck, Mylan, Bayer HealthCare, Pfizer, ANGELINI, Biological E, CCEPCD, Huaxin Pharmaceutical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Cyanocobalamin Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Cyanocobalamin Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Cyanocobalamin Injection Market report?

Ans: The main players in the Cyanocobalamin Injection Market are Luitpold Pharmaceuticals, Luitpold Pharmaceuticals(Daiichi Sankyo), Endo International, Bristol-Myers Squibb, Sanofi-Aventis, Jamieson, Teva(Actavis), Merck, Mylan, Bayer HealthCare, Pfizer, ANGELINI, Biological E, CCEPCD, Huaxin Pharmaceutical

What are the Application segmentation covered in the Cyanocobalamin Injection Market report?

Ans: The Applications covered in the Cyanocobalamin Injection Market report are Hospitals, Clinics, Others

What are the Type segmentation covered in the Cyanocobalamin Injection Market report?

Ans: The Types covered in the Cyanocobalamin Injection Market report are Vitamins, Supplements

1 Cyanocobalamin Injection Market Overview
1.1 Product Definition
1.2 Cyanocobalamin Injection by Type
1.2.1 Global Cyanocobalamin Injection Market Value Comparison by Type (2024 VS 2031)
1.2.2 Vitamins
1.2.3 Supplements
1.3 Cyanocobalamin Injection by Application
1.3.1 Global Cyanocobalamin Injection Market Value by Application (2024 VS 2031)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Global Cyanocobalamin Injection Market Size Estimates and Forecasts
1.4.1 Global Cyanocobalamin Injection Revenue 2020-2031
1.4.2 Global Cyanocobalamin Injection Sales 2020-2031
1.4.3 Global Cyanocobalamin Injection Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Cyanocobalamin Injection Market Competition by Manufacturers
2.1 Global Cyanocobalamin Injection Sales Market Share by Manufacturers (2020-2025)
2.2 Global Cyanocobalamin Injection Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Cyanocobalamin Injection Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Cyanocobalamin Injection, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Cyanocobalamin Injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Cyanocobalamin Injection, Product Type & Application
2.7 Global Key Manufacturers of Cyanocobalamin Injection, Date of Enter into This Industry
2.8 Global Cyanocobalamin Injection Market Competitive Situation and Trends
2.8.1 Global Cyanocobalamin Injection Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Cyanocobalamin Injection Players Market Share by Revenue
2.8.3 Global Cyanocobalamin Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Cyanocobalamin Injection Market Scenario by Region
3.1 Global Cyanocobalamin Injection Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Cyanocobalamin Injection Sales by Region: 2020-2031
3.2.1 Global Cyanocobalamin Injection Sales by Region: 2020-2025
3.2.2 Global Cyanocobalamin Injection Sales by Region: 2026-2031
3.3 Global Cyanocobalamin Injection Revenue by Region: 2020-2031
3.3.1 Global Cyanocobalamin Injection Revenue by Region: 2020-2025
3.3.2 Global Cyanocobalamin Injection Revenue by Region: 2026-2031
3.4 North America Cyanocobalamin Injection Market Facts & Figures by Country
3.4.1 North America Cyanocobalamin Injection Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Cyanocobalamin Injection Sales by Country (2020-2031)
3.4.3 North America Cyanocobalamin Injection Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Cyanocobalamin Injection Market Facts & Figures by Country
3.5.1 Europe Cyanocobalamin Injection Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Cyanocobalamin Injection Sales by Country (2020-2031)
3.5.3 Europe Cyanocobalamin Injection Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Cyanocobalamin Injection Market Facts & Figures by Region
3.6.1 Asia Pacific Cyanocobalamin Injection Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Cyanocobalamin Injection Sales by Region (2020-2031)
3.6.3 Asia Pacific Cyanocobalamin Injection Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Cyanocobalamin Injection Market Facts & Figures by Country
3.7.1 Latin America Cyanocobalamin Injection Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Cyanocobalamin Injection Sales by Country (2020-2031)
3.7.3 Latin America Cyanocobalamin Injection Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Cyanocobalamin Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Cyanocobalamin Injection Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Cyanocobalamin Injection Sales by Country (2020-2031)
3.8.3 Middle East and Africa Cyanocobalamin Injection Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Cyanocobalamin Injection Sales by Type (2020-2031)
4.1.1 Global Cyanocobalamin Injection Sales by Type (2020-2025)
4.1.2 Global Cyanocobalamin Injection Sales by Type (2026-2031)
4.1.3 Global Cyanocobalamin Injection Sales Market Share by Type (2020-2031)
4.2 Global Cyanocobalamin Injection Revenue by Type (2020-2031)
4.2.1 Global Cyanocobalamin Injection Revenue by Type (2020-2025)
4.2.2 Global Cyanocobalamin Injection Revenue by Type (2026-2031)
4.2.3 Global Cyanocobalamin Injection Revenue Market Share by Type (2020-2031)
4.3 Global Cyanocobalamin Injection Price by Type (2020-2031)
5 Segment by Application
5.1 Global Cyanocobalamin Injection Sales by Application (2020-2031)
5.1.1 Global Cyanocobalamin Injection Sales by Application (2020-2025)
5.1.2 Global Cyanocobalamin Injection Sales by Application (2026-2031)
5.1.3 Global Cyanocobalamin Injection Sales Market Share by Application (2020-2031)
5.2 Global Cyanocobalamin Injection Revenue by Application (2020-2031)
5.2.1 Global Cyanocobalamin Injection Revenue by Application (2020-2025)
5.2.2 Global Cyanocobalamin Injection Revenue by Application (2026-2031)
5.2.3 Global Cyanocobalamin Injection Revenue Market Share by Application (2020-2031)
5.3 Global Cyanocobalamin Injection Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Luitpold Pharmaceuticals
6.1.1 Luitpold Pharmaceuticals Company Information
6.1.2 Luitpold Pharmaceuticals Description and Business Overview
6.1.3 Luitpold Pharmaceuticals Cyanocobalamin Injection Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Luitpold Pharmaceuticals Cyanocobalamin Injection Product Portfolio
6.1.5 Luitpold Pharmaceuticals Recent Developments/Updates
6.2 Luitpold Pharmaceuticals(Daiichi Sankyo)
6.2.1 Luitpold Pharmaceuticals(Daiichi Sankyo) Company Information
6.2.2 Luitpold Pharmaceuticals(Daiichi Sankyo) Description and Business Overview
6.2.3 Luitpold Pharmaceuticals(Daiichi Sankyo) Cyanocobalamin Injection Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Luitpold Pharmaceuticals(Daiichi Sankyo) Cyanocobalamin Injection Product Portfolio
6.2.5 Luitpold Pharmaceuticals(Daiichi Sankyo) Recent Developments/Updates
6.3 Endo International
6.3.1 Endo International Company Information
6.3.2 Endo International Description and Business Overview
6.3.3 Endo International Cyanocobalamin Injection Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Endo International Cyanocobalamin Injection Product Portfolio
6.3.5 Endo International Recent Developments/Updates
6.4 Bristol-Myers Squibb
6.4.1 Bristol-Myers Squibb Company Information
6.4.2 Bristol-Myers Squibb Description and Business Overview
6.4.3 Bristol-Myers Squibb Cyanocobalamin Injection Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Bristol-Myers Squibb Cyanocobalamin Injection Product Portfolio
6.4.5 Bristol-Myers Squibb Recent Developments/Updates
6.5 Sanofi-Aventis
6.5.1 Sanofi-Aventis Company Information
6.5.2 Sanofi-Aventis Description and Business Overview
6.5.3 Sanofi-Aventis Cyanocobalamin Injection Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Sanofi-Aventis Cyanocobalamin Injection Product Portfolio
6.5.5 Sanofi-Aventis Recent Developments/Updates
6.6 Jamieson
6.6.1 Jamieson Company Information
6.6.2 Jamieson Description and Business Overview
6.6.3 Jamieson Cyanocobalamin Injection Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Jamieson Cyanocobalamin Injection Product Portfolio
6.6.5 Jamieson Recent Developments/Updates
6.7 Teva(Actavis)
6.7.1 Teva(Actavis) Company Information
6.7.2 Teva(Actavis) Description and Business Overview
6.7.3 Teva(Actavis) Cyanocobalamin Injection Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Teva(Actavis) Cyanocobalamin Injection Product Portfolio
6.7.5 Teva(Actavis) Recent Developments/Updates
6.8 Merck
6.8.1 Merck Company Information
6.8.2 Merck Description and Business Overview
6.8.3 Merck Cyanocobalamin Injection Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Merck Cyanocobalamin Injection Product Portfolio
6.8.5 Merck Recent Developments/Updates
6.9 Mylan
6.9.1 Mylan Company Information
6.9.2 Mylan Description and Business Overview
6.9.3 Mylan Cyanocobalamin Injection Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Mylan Cyanocobalamin Injection Product Portfolio
6.9.5 Mylan Recent Developments/Updates
6.10 Bayer HealthCare
6.10.1 Bayer HealthCare Company Information
6.10.2 Bayer HealthCare Description and Business Overview
6.10.3 Bayer HealthCare Cyanocobalamin Injection Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Bayer HealthCare Cyanocobalamin Injection Product Portfolio
6.10.5 Bayer HealthCare Recent Developments/Updates
6.11 Pfizer
6.11.1 Pfizer Company Information
6.11.2 Pfizer Description and Business Overview
6.11.3 Pfizer Cyanocobalamin Injection Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Pfizer Cyanocobalamin Injection Product Portfolio
6.11.5 Pfizer Recent Developments/Updates
6.12 ANGELINI
6.12.1 ANGELINI Company Information
6.12.2 ANGELINI Description and Business Overview
6.12.3 ANGELINI Cyanocobalamin Injection Sales, Revenue and Gross Margin (2020-2025)
6.12.4 ANGELINI Cyanocobalamin Injection Product Portfolio
6.12.5 ANGELINI Recent Developments/Updates
6.13 Biological E
6.13.1 Biological E Company Information
6.13.2 Biological E Description and Business Overview
6.13.3 Biological E Cyanocobalamin Injection Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Biological E Cyanocobalamin Injection Product Portfolio
6.13.5 Biological E Recent Developments/Updates
6.14 CCEPCD
6.14.1 CCEPCD Company Information
6.14.2 CCEPCD Description and Business Overview
6.14.3 CCEPCD Cyanocobalamin Injection Sales, Revenue and Gross Margin (2020-2025)
6.14.4 CCEPCD Cyanocobalamin Injection Product Portfolio
6.14.5 CCEPCD Recent Developments/Updates
6.15 Huaxin Pharmaceutical
6.15.1 Huaxin Pharmaceutical Company Information
6.15.2 Huaxin Pharmaceutical Description and Business Overview
6.15.3 Huaxin Pharmaceutical Cyanocobalamin Injection Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Huaxin Pharmaceutical Cyanocobalamin Injection Product Portfolio
6.15.5 Huaxin Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Cyanocobalamin Injection Industry Chain Analysis
7.2 Cyanocobalamin Injection Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Cyanocobalamin Injection Production Mode & Process Analysis
7.4 Cyanocobalamin Injection Sales and Marketing
7.4.1 Cyanocobalamin Injection Sales Channels
7.4.2 Cyanocobalamin Injection Distributors
7.5 Cyanocobalamin Injection Customer Analysis
8 Cyanocobalamin Injection Market Dynamics
8.1 Cyanocobalamin Injection Industry Trends
8.2 Cyanocobalamin Injection Market Drivers
8.3 Cyanocobalamin Injection Market Challenges
8.4 Cyanocobalamin Injection Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Luitpold Pharmaceuticals
Luitpold Pharmaceuticals (Daiichi Sankyo)
Endo International
Bristol–Myers Squibb
Sanofi Aventis
Jamieson
Teva (Actavis)
Merck
Mylan NV
Bayer HealthCare
Pfizer Inc
Angelini
Biological E.
CCEPCD
Huaxin Pharmaceutical
List of Tables
 Table 1. Global Cyanocobalamin Injection Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Cyanocobalamin Injection Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Cyanocobalamin Injection Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Cyanocobalamin Injection Sales (K Doses) of Key Manufacturers (2020-2025)
 Table 5. Global Cyanocobalamin Injection Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Cyanocobalamin Injection Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Cyanocobalamin Injection Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Cyanocobalamin Injection Average Price (USD/Dose) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Cyanocobalamin Injection, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Cyanocobalamin Injection, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Cyanocobalamin Injection, Product Type & Application
 Table 12. Global Key Manufacturers of Cyanocobalamin Injection, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Cyanocobalamin Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cyanocobalamin Injection as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Cyanocobalamin Injection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Cyanocobalamin Injection Sales by Region (2020-2025) & (K Doses)
 Table 18. Global Cyanocobalamin Injection Sales Market Share by Region (2020-2025)
 Table 19. Global Cyanocobalamin Injection Sales by Region (2026-2031) & (K Doses)
 Table 20. Global Cyanocobalamin Injection Sales Market Share by Region (2026-2031)
 Table 21. Global Cyanocobalamin Injection Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Cyanocobalamin Injection Revenue Market Share by Region (2020-2025)
 Table 23. Global Cyanocobalamin Injection Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Cyanocobalamin Injection Revenue Market Share by Region (2026-2031)
 Table 25. North America Cyanocobalamin Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Cyanocobalamin Injection Sales by Country (2020-2025) & (K Doses)
 Table 27. North America Cyanocobalamin Injection Sales by Country (2026-2031) & (K Doses)
 Table 28. North America Cyanocobalamin Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Cyanocobalamin Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Cyanocobalamin Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Cyanocobalamin Injection Sales by Country (2020-2025) & (K Doses)
 Table 32. Europe Cyanocobalamin Injection Sales by Country (2026-2031) & (K Doses)
 Table 33. Europe Cyanocobalamin Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Cyanocobalamin Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Cyanocobalamin Injection Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Cyanocobalamin Injection Sales by Region (2020-2025) & (K Doses)
 Table 37. Asia Pacific Cyanocobalamin Injection Sales by Region (2026-2031) & (K Doses)
 Table 38. Asia Pacific Cyanocobalamin Injection Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Cyanocobalamin Injection Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Cyanocobalamin Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Cyanocobalamin Injection Sales by Country (2020-2025) & (K Doses)
 Table 42. Latin America Cyanocobalamin Injection Sales by Country (2026-2031) & (K Doses)
 Table 43. Latin America Cyanocobalamin Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Cyanocobalamin Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Cyanocobalamin Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Cyanocobalamin Injection Sales by Country (2020-2025) & (K Doses)
 Table 47. Middle East and Africa Cyanocobalamin Injection Sales by Country (2026-2031) & (K Doses)
 Table 48. Middle East and Africa Cyanocobalamin Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Cyanocobalamin Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Cyanocobalamin Injection Sales (K Doses) by Type (2020-2025)
 Table 51. Global Cyanocobalamin Injection Sales (K Doses) by Type (2026-2031)
 Table 52. Global Cyanocobalamin Injection Sales Market Share by Type (2020-2025)
 Table 53. Global Cyanocobalamin Injection Sales Market Share by Type (2026-2031)
 Table 54. Global Cyanocobalamin Injection Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Cyanocobalamin Injection Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Cyanocobalamin Injection Revenue Market Share by Type (2020-2025)
 Table 57. Global Cyanocobalamin Injection Revenue Market Share by Type (2026-2031)
 Table 58. Global Cyanocobalamin Injection Price (USD/Dose) by Type (2020-2025)
 Table 59. Global Cyanocobalamin Injection Price (USD/Dose) by Type (2026-2031)
 Table 60. Global Cyanocobalamin Injection Sales (K Doses) by Application (2020-2025)
 Table 61. Global Cyanocobalamin Injection Sales (K Doses) by Application (2026-2031)
 Table 62. Global Cyanocobalamin Injection Sales Market Share by Application (2020-2025)
 Table 63. Global Cyanocobalamin Injection Sales Market Share by Application (2026-2031)
 Table 64. Global Cyanocobalamin Injection Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Cyanocobalamin Injection Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Cyanocobalamin Injection Revenue Market Share by Application (2020-2025)
 Table 67. Global Cyanocobalamin Injection Revenue Market Share by Application (2026-2031)
 Table 68. Global Cyanocobalamin Injection Price (USD/Dose) by Application (2020-2025)
 Table 69. Global Cyanocobalamin Injection Price (USD/Dose) by Application (2026-2031)
 Table 70. Luitpold Pharmaceuticals Company Information
 Table 71. Luitpold Pharmaceuticals Description and Business Overview
 Table 72. Luitpold Pharmaceuticals Cyanocobalamin Injection Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
 Table 73. Luitpold Pharmaceuticals Cyanocobalamin Injection Product
 Table 74. Luitpold Pharmaceuticals Recent Developments/Updates
 Table 75. Luitpold Pharmaceuticals(Daiichi Sankyo) Company Information
 Table 76. Luitpold Pharmaceuticals(Daiichi Sankyo) Description and Business Overview
 Table 77. Luitpold Pharmaceuticals(Daiichi Sankyo) Cyanocobalamin Injection Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
 Table 78. Luitpold Pharmaceuticals(Daiichi Sankyo) Cyanocobalamin Injection Product
 Table 79. Luitpold Pharmaceuticals(Daiichi Sankyo) Recent Developments/Updates
 Table 80. Endo International Company Information
 Table 81. Endo International Description and Business Overview
 Table 82. Endo International Cyanocobalamin Injection Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
 Table 83. Endo International Cyanocobalamin Injection Product
 Table 84. Endo International Recent Developments/Updates
 Table 85. Bristol-Myers Squibb Company Information
 Table 86. Bristol-Myers Squibb Description and Business Overview
 Table 87. Bristol-Myers Squibb Cyanocobalamin Injection Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
 Table 88. Bristol-Myers Squibb Cyanocobalamin Injection Product
 Table 89. Bristol-Myers Squibb Recent Developments/Updates
 Table 90. Sanofi-Aventis Company Information
 Table 91. Sanofi-Aventis Description and Business Overview
 Table 92. Sanofi-Aventis Cyanocobalamin Injection Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
 Table 93. Sanofi-Aventis Cyanocobalamin Injection Product
 Table 94. Sanofi-Aventis Recent Developments/Updates
 Table 95. Jamieson Company Information
 Table 96. Jamieson Description and Business Overview
 Table 97. Jamieson Cyanocobalamin Injection Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
 Table 98. Jamieson Cyanocobalamin Injection Product
 Table 99. Jamieson Recent Developments/Updates
 Table 100. Teva(Actavis) Company Information
 Table 101. Teva(Actavis) Description and Business Overview
 Table 102. Teva(Actavis) Cyanocobalamin Injection Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
 Table 103. Teva(Actavis) Cyanocobalamin Injection Product
 Table 104. Teva(Actavis) Recent Developments/Updates
 Table 105. Merck Company Information
 Table 106. Merck Description and Business Overview
 Table 107. Merck Cyanocobalamin Injection Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
 Table 108. Merck Cyanocobalamin Injection Product
 Table 109. Merck Recent Developments/Updates
 Table 110. Mylan Company Information
 Table 111. Mylan Description and Business Overview
 Table 112. Mylan Cyanocobalamin Injection Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
 Table 113. Mylan Cyanocobalamin Injection Product
 Table 114. Mylan Recent Developments/Updates
 Table 115. Bayer HealthCare Company Information
 Table 116. Bayer HealthCare Description and Business Overview
 Table 117. Bayer HealthCare Cyanocobalamin Injection Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
 Table 118. Bayer HealthCare Cyanocobalamin Injection Product
 Table 119. Bayer HealthCare Recent Developments/Updates
 Table 120. Pfizer Company Information
 Table 121. Pfizer Description and Business Overview
 Table 122. Pfizer Cyanocobalamin Injection Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
 Table 123. Pfizer Cyanocobalamin Injection Product
 Table 124. Pfizer Recent Developments/Updates
 Table 125. ANGELINI Company Information
 Table 126. ANGELINI Description and Business Overview
 Table 127. ANGELINI Cyanocobalamin Injection Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
 Table 128. ANGELINI Cyanocobalamin Injection Product
 Table 129. ANGELINI Recent Developments/Updates
 Table 130. Biological E Company Information
 Table 131. Biological E Description and Business Overview
 Table 132. Biological E Cyanocobalamin Injection Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
 Table 133. Biological E Cyanocobalamin Injection Product
 Table 134. Biological E Recent Developments/Updates
 Table 135. CCEPCD Company Information
 Table 136. CCEPCD Description and Business Overview
 Table 137. CCEPCD Cyanocobalamin Injection Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
 Table 138. CCEPCD Cyanocobalamin Injection Product
 Table 139. CCEPCD Recent Developments/Updates
 Table 140. Huaxin Pharmaceutical Company Information
 Table 141. Huaxin Pharmaceutical Description and Business Overview
 Table 142. Huaxin Pharmaceutical Cyanocobalamin Injection Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
 Table 143. Huaxin Pharmaceutical Cyanocobalamin Injection Product
 Table 144. Huaxin Pharmaceutical Recent Developments/Updates
 Table 145. Key Raw Materials Lists
 Table 146. Raw Materials Key Suppliers Lists
 Table 147. Cyanocobalamin Injection Distributors List
 Table 148. Cyanocobalamin Injection Customers List
 Table 149. Cyanocobalamin Injection Market Trends
 Table 150. Cyanocobalamin Injection Market Drivers
 Table 151. Cyanocobalamin Injection Market Challenges
 Table 152. Cyanocobalamin Injection Market Restraints
 Table 153. Research Programs/Design for This Report
 Table 154. Key Data Information from Secondary Sources
 Table 155. Key Data Information from Primary Sources
 Table 156. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Cyanocobalamin Injection
 Figure 2. Global Cyanocobalamin Injection Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Cyanocobalamin Injection Market Share by Type: 2024 & 2031
 Figure 4. Vitamins Product Picture
 Figure 5. Supplements Product Picture
 Figure 6. Global Cyanocobalamin Injection Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Cyanocobalamin Injection Market Share by Application: 2024 & 2031
 Figure 8. Hospitals
 Figure 9. Clinics
 Figure 10. Others
 Figure 11. Global Cyanocobalamin Injection Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Cyanocobalamin Injection Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Cyanocobalamin Injection Sales (2020-2031) & (K Doses)
 Figure 14. Global Cyanocobalamin Injection Average Price (USD/Dose) & (2020-2031)
 Figure 15. Cyanocobalamin Injection Report Years Considered
 Figure 16. Cyanocobalamin Injection Sales Share by Manufacturers in 2024
 Figure 17. Global Cyanocobalamin Injection Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest Cyanocobalamin Injection Players: Market Share by Revenue in Cyanocobalamin Injection in 2024
 Figure 19. Cyanocobalamin Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global Cyanocobalamin Injection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America Cyanocobalamin Injection Sales Market Share by Country (2020-2031)
 Figure 22. North America Cyanocobalamin Injection Revenue Market Share by Country (2020-2031)
 Figure 23. U.S. Cyanocobalamin Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada Cyanocobalamin Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe Cyanocobalamin Injection Sales Market Share by Country (2020-2031)
 Figure 26. Europe Cyanocobalamin Injection Revenue Market Share by Country (2020-2031)
 Figure 27. Germany Cyanocobalamin Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France Cyanocobalamin Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. Cyanocobalamin Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy Cyanocobalamin Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia Cyanocobalamin Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Cyanocobalamin Injection Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific Cyanocobalamin Injection Revenue Market Share by Region (2020-2031)
 Figure 34. China Cyanocobalamin Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan Cyanocobalamin Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea Cyanocobalamin Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India Cyanocobalamin Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia Cyanocobalamin Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Taiwan Cyanocobalamin Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Indonesia Cyanocobalamin Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Thailand Cyanocobalamin Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Malaysia Cyanocobalamin Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Philippines Cyanocobalamin Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Latin America Cyanocobalamin Injection Sales Market Share by Country (2020-2031)
 Figure 45. Latin America Cyanocobalamin Injection Revenue Market Share by Country (2020-2031)
 Figure 46. Mexico Cyanocobalamin Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Brazil Cyanocobalamin Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Argentina Cyanocobalamin Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Middle East and Africa Cyanocobalamin Injection Sales Market Share by Country (2020-2031)
 Figure 50. Middle East and Africa Cyanocobalamin Injection Revenue Market Share by Country (2020-2031)
 Figure 51. Turkey Cyanocobalamin Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Saudi Arabia Cyanocobalamin Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. U.A.E Cyanocobalamin Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Global Sales Market Share of Cyanocobalamin Injection by Type (2020-2031)
 Figure 55. Global Revenue Market Share of Cyanocobalamin Injection by Type (2020-2031)
 Figure 56. Global Cyanocobalamin Injection Price (USD/Dose) by Type (2020-2031)
 Figure 57. Global Sales Market Share of Cyanocobalamin Injection by Application (2020-2031)
 Figure 58. Global Revenue Market Share of Cyanocobalamin Injection by Application (2020-2031)
 Figure 59. Global Cyanocobalamin Injection Price (USD/Dose) by Application (2020-2031)
 Figure 60. Cyanocobalamin Injection Value Chain
 Figure 61. Channels of Distribution (Direct Vs Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Accenture

SIMILAR REPORTS

Global Cyanocobalamin Spray Market Research Report 2024
Cyanocobalamin Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Vitamin B12 Cobalamin Cyanocobalamin Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Mecobalamin Injection Market Research Report 2024
Global Vitamin B12 Cobalamin Market Research Report 2024
Global Adenosine Cobalamin Market Research Report 2024
Global Adenosylcobalamin Tablets Market Research Report 2024
Mecobalamin Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Vitamin B12 Series API Market Research Report 2024
Global Vitamin B12 Deficiency Treatment Market Research Report 2025
Global Mecobalamin Market Research Report 2024
Global B12 Patches Market Research Report 2024
Global Mecobalamin Methylcobalamin API Market Research Report 2024
Mecobalamin Tablet Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Cyanocobalamin API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Vitamin B1 Thiamine Mononitrate Market Insights Forecast to 2030
Global Vitamin Shot Market Research Report 2025
Vitamin B12 Feed Additive Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Active B12 Test Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Vitamin B12 Gummy Market Research Report 2025

RELATED REPORTS

Global Taurine and Derivatives Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-26D19461
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global OTC Hydrotalcite Chewable Tablets Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-18S16538
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Women's Fat Burners Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14W1499
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Yohimbine Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35Y1251
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions